Clinical Trial Update: CAN1012 in Pre-Malignant DCIS and LCIS [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for CAN1012 in pre-malignant breast conditions ductal carcinoma in situ and lobular carcinoma in situ; the study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ductal Carcinoma in Situ
• Lobular Carcinoma in Situ

Drugs mentioned

• CAN1012

Snippet

Sponsor: Providence Health & Services | Conditions: Ductal Carcinoma in Situ, Lobular Carcinoma in Situ | Phase 1 | Status: NOT_YET_RECRUITING